ASCO Publishes Position Statement on Cancer Health Disparities

Share this content:
ASCO recommends that institutions and practices develop and enforce policies that support culturally competent SGM care and prohibit discrimination against SGM patients and providers.
ASCO recommends that institutions and practices develop and enforce policies that support culturally competent SGM care and prohibit discrimination against SGM patients and providers.

The American Society of Clinical Oncology (ASCO) published a position statement on reducing cancer health disparities to address the needs of patients, caregivers, and the oncology workforce who identify as part of the sexual and gender minority (SGM) population. The statement was published in the Journal of Clinical Oncology.1

There is a disproportionate cancer burden among members of the SGM population, which encompasses those who are lesbian, gay, bisexual, transgender, and intersex.

ASCO formed a Health Disparities Committee that identified 5 areas that must be addressed to reduce cancer health disparities: patient education and support, workforce development and diversity, quality improvement strategies, research strategies, and policy solutions.

The recommendations to improve patient education and support include enhanced patient navigation and care coordination, more educational resources that are culturally competent and that address cancer prevention, and the creation of safe spaces.

ASCO recommends that workforce development should include cultural and SGM training so that providers are knowledgeable of SGM-specific issues, but also to reduce discrimination against health care providers who identify as an SGM.

The call for quality improvement strategies includes collection of SGM-related data for use to improve or individualize care. The position statement also highlights the need for research strategies to increase knowledge of the health care needs and outcomes of the SGM population.

ASCO recommends that institutions and practices develop and enforce policies that support culturally competent SGM care and prohibit discrimination against SGM patients and providers.

RELATED: ASCO's State of Cancer Care 2017 Report Emphasizes Persisting Barriers to Care

The committee wrote that to correct the suboptimal access to cancer prevention, screening, and care experienced by the SGM population, “it is necessary to address barriers at many levels, including interpersonal and institutional barriers to optimal care and outcomes.”

Reference

  1. Griggs J, Maingi S, Blinder V, et al. American Society of Clinical Oncology position statement: strategies for reducing cancer health disparities among sexual and gender minority populations. J Clin Oncol. 2017 Apr 3. doi: 10.1200/JCO.2016.72.0441 [Epub ahead of print]

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters